Concepedia

Xiao Hu

XH

Statistics

Publications

8

Citations

416

H-Index

8

Active since

2018

Affiliations

Nankai University(Current)

Tianjin Stomatological Hospital

First Hospital of Qinhuangdao

Tianjin Medical University Cancer Institute and Hospital

Tianjin Nankai Hospital

Xiao Hu is an author at Nankai University specializing in oncology, medicine, and molecular oncology.

ORCID

Publications per year

2018–2022

8

Publications

8

The PI3K/Akt/GSK-3β/ROS/eIF2B pathway promotes breast cancer growth and metastasis via suppression of NK cell cytotoxicity and tumor cell susceptibility

Jin Fengjiao, Wu Zhaozhen, Xiao Hu et al. · Cancer Biology and Medicine · 2019 · 137 citations · Full text

, , +17

Downregulation of <scp>MCT</scp>4 for lactate exchange promotes the cytotoxicity of <scp>NK</scp> cells in breast carcinoma

Yaping Long, Zihe Gao, Xiao Hu et al. · Cancer Medicine · 2018 · 59 citations · Full text

, , +15

Activation of β2-Adrenergic Receptor Promotes Growth and Angiogenesis in Breast Cancer by Down-regulating PPARγ

Jing Zhou, Zhanzhao Liu, Ling‐Jing Zhang et al. · Cancer Research and Treatment · 2020 · 58 citations · Full text

, , +17

IDO1 impairs NK cell cytotoxicity by decreasing NKG2D/NKG2DLs via promoting miR-18a

Xiao Han, Xiao Hu, Fengjiao Jin et al. · Molecular Immunology · 2018 · 47 citations

, , +10

Glucagon-like peptide-1 receptor activation by liraglutide promotes breast cancer through NOX4/ROS/VEGF pathway

Zhanzhao Liu, Xianxian Duan, Mengci Yuan et al. · Life Sciences · 2022 · 41 citations

, , +13

1–5 of 8